In August 2019, Ayesha Sitlani, Associate Vice President, Antibody Strategy, IAVI, introduced a new IAVI initiative: a project to understand the gaps and opportunities for sustainable and global access to monoclonal ...
Monoclonal antibodies have changed the way we treat many diseases. They are a promising treatment for COVID-19, and IAVI is committed ...
Resulting knowledge and capacity continue to advance HIV vaccine research globally
Expert insights on a range of issues related to COVID-19, including media communication, community engagement, and mental health
Raising awareness of one of the world’s biggest hidden health crises
Updated September 15, 2020
Findings published in Cell Reports may guide HIV vaccine developers
Insights to the challenges in pursuing and succeeding at STEM careers faced by women in Africa, and a multipronged approach to ...
A roadmap to making monoclonal antibodies, one of the most powerful tools in modern medicine, affordable and available to all.
By Ethel Makila, Associate Director, Advocacy Policy and Communications, IAVI